. However, the effects of NF-B activation on oligodendrocytes in MS and EAE remain unknown. We generated a mouse model that expresses IB␣⌬N, a super-suppressor of NF-B, specifically in oligodendrocytes and demonstrated that IB␣⌬N expression had no effect on oligodendrocytes under normal conditions (both sexes). Interestingly, we showed that oligodendrocytespecific expression of IB␣⌬N blocked NF-B activation in oligodendrocytes and resulted in exacerbated oligodendrocyte death and hypomyelination in young, developing mice that express IFN-␥ ectopically in the CNS (both sexes). We also showed that NF-B inactivation in oligodendrocytes aggravated IFN-␥-induced remyelinating oligodendrocyte death and remyelination failure in the cuprizone model (male mice). Moreover, we found that NF-B inactivation in oligodendrocytes increased the susceptibility of mice to EAE (female mice). These findings imply the cytoprotective effects of NF-B activation on oligodendrocytes in MS and EAE.
Introduction
Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), are inflammatory demyelinating diseases of the CNS characterized by inflammation, demyelination, oligodendrocyte death, and axon degeneration (Frohman et al., 2006; Bradl and Lassmann, 2010) . It is believed that mature oligodendrocyte death induced by inflammation contributes significantly to the pathogenesis of MS and EAE. A number of studies have shown that protection of mature oligodendrocytes against inflammation decreases the susceptibility of mice to EAE (Hisahara et al., 2003; Mc Guire et al., 2010; Prineas and Parratt, 2012; Lin et al., 2013) . Oligodendrocyte regeneration is necessary to repair myelin damage in MS lesions; however, remyelinating oligodendrocytes are prone to apoptosis under inflammatory conditions (Franklin and ffrench-Constant, 2008; Watzlawik et al., 2010; Stone and Lin, 2015) . One of the major challenges in MS research is to understand the mechanisms governing the viability of oligodendrocytes and to develop therapeutic strategies that promote oligodendrocyte survival.
The transcription factor NF-B is a heterodimer or homodimer of the Rel family of proteins, including p65, c-Rel, RelB, p50, and p52. In the quiescent state, NF-B remains inactive in the cytoplasm through interaction with NF-B inhibitors (IBs). Activation of NF-B involves dissociation from IBs and trans-location into the nucleus, where NF-B binds to the B consensus DNA sequence and stimulates transcription of genes that regulate inflammation, cell viability, and cell functions. NF-B can be activated in a variety of ways, including the IB kinase 2 (IKK2)-dependent canonical pathway, the noncanonical pathway, and atypical pathways (Hayden and Ghosh, 2012; MinchevaTasheva and Soler, 2013) . It is known that NF-B plays a critical role in MS and EAE (Yan and Greer, 2008; Mc Guire et al., 2013) . NF-B is activated in multiple cell types in MS and EAE, including oligodendrocytes, T cells, astrocytes, and microglia/macrophages (Gveric et al., 1998; Bonetti et al., 1999; Lin et al., 2013) . A number of studies have shown that NF-B activation in T cells, microglia/macrophages, or astrocytes promotes the development of MS and EAE by facilitating inflammation (Brambilla et al., 2009; Mc Guire et al., 2013; Yin et al., 2013; Hao et al., 2016) .
In vitro studies suggest that NF-B activation promotes oligodendrocyte survival in response to inflammatory mediators (Nicholas et al., 2001; Hamanoue et al., 2004; Lin et al., 2012) . In contrast, one study briefly mentions that IKK2 deletion in oligodendrocytes using the Cre/loxP approach by crossing floxed IKK2 mice (IKK2 FL mice) with mice expressing Cre under the myelin oligodendrocyte glycoprotein (MOG) promoter (MOG/ Cre mice) does not alter the EAE disease course (Raasch et al., 2011) . However, the study falls short of excluding the following possibilities: (1) that NF-B activation is not attenuated in oligodendrocytes of IKK2 FL ;MOG/Cre mice during EAE due to insufficient efficiency of Cre-mediated recombination and/or compensation from other NF-B activating pathways and (2) that inflammation is compromised in IKK2 FL ;MOG/Cre mice undergoing EAE due to undesired leaky expression of Cre in inflammatory cells. The minimal alteration of EAE disease course in IKK2
FL ;MOG/Cre mice does not rule out the significant impact of NF-B activation on oligodendrocytes during EAE. Therefore, the effects of NF-B activation on oligodendrocytes in MS and EAE remain ambiguous.
Our previous studies demonstrated that NF-B is activated in oligodendrocytes in the CNS of mice undergoing EAE and mice that express IFN-␥, a key proinflammatory cytokine in MS and EAE, ectopically in the CNS (Lin et al., 2012 . Importantly, our previous in vitro study showed that expression of IB␣⌬N, a super-suppressor of NF-B, is sufficient to block NF-B activation in the oligodendroglial cell line Oli-neu in response to IFN-␥ and render the cells sensitive to this cytokine (Lin et al., 2012) . Therefore, in this study, we sought to determine the role of NF-B activation in oligodendrocytes in models of MS by exploiting a mouse model that expresses IB␣⌬N specifically in oligodendrocytes. Our findings indicate the cytoprotective effects of NF-B activation on oligodendrocytes in MS and EAE.
Materials and Methods
Mice, cuprizone treatment, and EAE immunization. A summary of mouse lines can be found in Table 1 and a summary of experimental genotypes and crosses can be found in Lin et al., 2004) . To repress the expression of the IFN-␥ transgene in the astrocytes of GFAP/tTA;TRE/IFN-␥; cloxPIB␣⌬N;CNP/Cre mice and GFAP/tTA;TRE/IFN-␥ mice, 0.05 mg/ml doxycycline (Dox) was added to the drinking water and provided ad libitum from conception (Lin et al., , 2005 .
To induce demyelination with cuprizone, 6-week-old male mice were fed a diet of mouse chow containing 0.2% cuprizone (Sigma-Aldrich) for up to 6 weeks. Subsequently, mice were returned to a normal diet for 3 weeks to allow remyelination to occur (Lin et al., , 2014 . To induce EAE, 8-week-old female mice were injected subcutaneously in the flank and at the tail base with 200 g of MOG 35-55 peptide emulsified in complete Freund's adjuvant (BD Biosciences) supplemented with 600 g of Mycobacterium tuberculosis (strain H37Ra; BD Biosciences). Two intraperitoneal injections of 400 ng of pertussis toxin (List Biological Laboratories) were given 24 and 72 h later. Clinical scores (0 ϭ healthy, 1 ϭ flaccid tail, 2 ϭ ataxia and/or paresis of hindlimbs, 3 ϭ paralysis of hindlimbs and/or paresis of forelimbs, 4 ϭ tetraparalysis, 5 ϭ moribund or death) were recorded daily (Lin et al., 2007 (Lin et al., , 2014 .
All animal procedures were conducted in complete compliance with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of Minnesota.
PCR and real-time PCR. Deeply anesthetized mice were perfused with ice-cold PBS. Genomic DNA was isolated from the indicated tissues and PCR was performed to determine the removal of the floxed STOP cassette that prevents IB␣⌬N translation by Cre recombination in cloxPIB␣⌬N;CNP/Cre mice as described previously (Schmidt-Ullrich et al., 2001) . RNA was isolated from brain using TRIzol reagent (Invitrogen) and treated with DNaseI (Invitrogen) to eliminate genomic DNA. Reverse transcription was performed using the iScript cDNA Synthesis Kit (Bio-Rad). TaqMan real-time PCR was performed with iQ Supermix (Bio-Rad) on the LightCycler 480 System (Roche) as described in our previous studies (Lin et al., , 2007 .
Western blot analysis. Brains harvested from mice were rinsed in icecold PBS and homogenized using a motorized homogenizer as described previously (Lin et al., 2005 . After incubating on ice for 15 min, the extracts were cleared by centrifugation twice at 14,000 rpm for 30 min. The protein content of each extract was determined by DC Protein Assay (Bio-Rad Laboratories). The extracts (40 g) were separated by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were incubated with a primary antibody against IB␣ (1:1000; Santa Cruz Biotechnology, RRID:AB_2235952) or ␤-actin (1:5000; SigmaAldrich, RRID:AB_476694), followed by an HRP-conjugated secondary antibody (1:1000; Vector Laboratories, RRID:AB_2336198). After incubation with ECL Detection Reagents (GE Healthcare Biosciences), the chemiluminescent signal was detected.
Immunohistochemistry (IHC) . Anesthetized mice were perfused through the left cardiac ventricle with 4% paraformaldehyde in PBS. The tissues were removed, postfixed with paraformaldehyde, cryopreserved in 30% sucrose, embedded in optimal cutting temperature compound, and frozen on dry ice. Frozen sections were cut using a cryostat at a thickness of 10 m. For immunohistochemistry, the sections were treated with Ϫ20°C acetone, blocked with PBS containing 10% goat serum and 0.1% Triton X-100, and incubated overnight with the primary antibody diluted in blocking solution. Fluorescein (Vector Laboratories, anti-rabbit, RRID:AB_2336197), Cy3 (Millipore, antimouse, RRID:AB_11213281, anti-rat, RRID:AB_90854), or enzymelabeled secondary antibodies (Vector Laboratories, anti-rat, RRID: For cuprizone-treated mice, coronal sections of the fornix region of the corpus callosum corresponding to Sidman sections 241-251 were selected for use and all comparative analyses were restricted to the midline corpus callosum (Sidman et al., 1971) . Immunopositive cells were quantified by counting positive cells within the median of the corpus callosum as described previously (Lin et al., , 2014 .
Toluidine blue staining and electron microscopy (EM) analysis. Mice were anesthetized and perfused with PBS containing 4% paraformaldehyde and 2.5% glutaraldehyde. The sciatic nerve, spinal cord, cerebellar white matter, and corpus callosum were processed and embedded. For cuprizone-treated mice, brains were sliced into 1 mm sections. The section corresponding to the region of the fornix was trimmed, processed, and oriented so that a cross-section of the corpus callosum was achieved. Thin sections were cut, stained with toluidine blue, and analyzed as described previously (Lin et al., , 2014 . Moreover, ultrathin sections were cut, stained with uranyl acetate and lead citrate, and analyzed as described previously (Lin et al., , 2014 . We counted the total number of axons, the number of myelinated axons, and calculated the percentage of myelinated axons as described previously Lin et al., 2014) .
T-cell proliferation assay and cytokine assay. Single-spleen cell suspensions were generated from mice with EAE at postimmunization day (PID) 10. Red blood cells were lysed with ACK lysis buffer (Invitrogen), washed, and plated at 5 ϫ 10 5 splenocytes per well in 96-well microtiter plates. Samples were plated in triplicate. The cells were treated with MOG35-55 peptide (0, 1, 10, or 100 g/ml) and incubated at 37°C and 5% CO 2 . After 48 h, 20 l of BrdU labeling solution (Millipore) was added to the culture medium for 24 h. Cell proliferation was determined using the Colorimetric BrdU Cell Proliferation kit (Millipore) according to manufacturer's instructions. We quantified the cytokines in the culture supernatants of triplicate wells using the ELISA kits (Thermo Scientific) according to the manufacturer's instructions.
Experimental design and statistical analysis. The sample size for each individual experiment is listed in the corresponding figure legend. For EAE experiments, only female mice were used due to the well known sex differences in EAE. For cuprizone studies, only male mice were used. For developmental studies, both male and female mice were used because no sex differences were observed. EAE clinical score data are presented as mean Ϯ SEM and were compared using a two-way ANOVA with a Sidak's multiple-comparisons test using GraphPad Prism 6 software (RRID:SCR_002798). All other data are expressed as mean Ϯ SD. Comparisons between two groups was evaluated by t test using GraphPad Prism 6 software. Multiple comparisons were evaluated statistically with one-way ANOVA with Tukey's posttest using GraphPad Prism 6 software. Phenotypic differences among groups were evaluated with the 2 test using GraphPad Prism 6 software. p Ͻ 0.05 was considered significant.
Results

NF-B is dispensable for oligodendrocytes under normal conditions
The primary function of oligodendrocytes is to produce the myelin that insulates axons in the CNS. Data indicate that NF-B has no significant effect on myelin formation and maintenance in the CNS under normal conditions (Blank and Prinz, 2014; Kretz et al., 2014) . Mice with deletions in the genes encoding c-Rel, RelB, or p52 do not exhibit myelin abnormalities in the CNS (Hilliard et al., 1999 (Hilliard et al., , 2002 . Similarly, mice with CNS-restricted deletion of p65, IKK1, IKK2, or IKK3 do not show any myelin defects in the CNS (van Loo et al., 2006; Kretz et al., 2014) . Nevertheless, a recent study shows that impaired NF-B activity is associated with myelin abnormalities in the CNS of patients with Xq28 duplication (Philippe et al., 2013) . We generated a mouse model that expresses IB␣⌬N, a deletion mutant lacking the N-terminal 36 aa of IB␣ that functions as a dominant inhibitor of NF-B signaling (Krappmann et al., 1996) , specifically in oligodendrocytes in the CNS and determined the potential role of NF-B in these cells under normal conditions. cloxPIB␣⌬N mice (Schmidt-Ullrich et al., 2001) were crossed with CNP/Cre knock-in mice (Lappe-Siefke et al., 2003) to obtain cloxPIB␣⌬N;CNP/Cre mice (IB␣⌬N ϩ mice) and control mice (IB␣⌬N Ϫ mice), including cloxPIB␣⌬N mice, CNP/Cre mice, and wild-type mice (Table 1 , 2). IB␣⌬N ϩ mice appeared healthy and were indistinguishable from littermate control mice. PCR analysis showed that the floxed STOP cassette that prevents IB␣⌬N translation was removed by Cre recombination in the CNS and PNS of IB␣⌬N ϩ mice (Fig. 1A) . Western blot analysis showed that IB␣⌬N was expressed in the CNS of IB␣⌬N ϩ mice ( Therefore, these results demonstrate that NF-B is dispensable for the viability and function of oligodendrocytes under normal conditions.
Several in vitro studies suggest that NF-B activation is required for Schwann cell differentiation and myelin formation in the PNS (Nickols et al., 2003; Limpert et al., 2013) . Nevertheless, a recent report showed that Schwann-cell-restricted deletion of IKK2 has no effect on myelin formation in the PNS in vivo (Morton et al., 2013). As described above, the floxed STOP cassette Mice were removed from Dox at E15 for developmental studies and on the first day of cuprizone treatment for cuprizone studies.
that prevents IB␣⌬N translation was also removed by Cre recombination in the PNS of IB␣⌬N ϩ mice. Interestingly, toluidine blue staining revealed normal myelination in the developing and adult PNS of IB␣⌬N ϩ mice compared with IB␣⌬N Ϫ mice (Fig. 2) . These data provide additional evidence that NF-B is not a major player in Schwann cell differentiation and myelin formation in the PNS under normal conditions.
NF-B inactivation specifically in myelinating oligodendrocytes exacerbates IFN-␥-induced hypomyelination in the developing CNS
Multiple pathological features of MS lesions are recapitulated in the developing CNS of mice that express IFN-␥ ectopically in the CNS, including oligodendrocyte death, myelin loss, T-cell infiltration, microglia/macrophage activation, and upregulation of inflammatory mediators (Corbin et al., 1996; LaFerla et al., 2000; Lin et al., 2014) . Using the tetracycline-controllable system, we have generated GFAP/tTA;TRE/IFN-␥ double-transgenic mice that allow for controllable expression of IFN-␥ in the CNS . We showed that the expression of the transgene IFN-␥ is repressed in GFAP/tTA;TRE/IFN-␥ double-transgenic mice treated with Dox and that IFN-␥ becomes detectable in the CNS of these mice after ϳ14 d of Dox removal (Lin et al., 2005 . Our previous studies showed that the presence of IFN-␥ in the CNS of young, developing mice stimulates inflammation, activates NF-B, and induces myelinating oligodendrocyte death and myelin loss (Lin et al., 2005 Lin et al., 2012 Lin et al., , 2014 . Therefore, we determined the effects of NF-B activation on myelinating oligodendrocytes under inflammatory conditions by using IFN-␥-expressing mice.
GFAP 
of GFAP/tTA;TRE/IFN-␥ mice never released from Dox served as controls (IFN-␥
. We found that a number of IFN-␥ ϩ ;IB␣⌬N Ϫ mice display tremor and ataxia as described in our previous studies (Lin et al., 2005 (Lin et al., , 2014 (Table 3) . Double immunostaining for ASPA (a marker for oligodendrocytes) and the active form of p65 showed that immunoreactivity for the active form of p65 was undetectable in the CNS of the control IFN-␥ Ϫ ;IB␣⌬N Ϫ mice and IFN-␥ Ϫ ;IB␣⌬N ϩ mice ( Fig. 3A-F, M ) . A number of cells, including ASPA-positive oligodendrocytes, were positive for the active form of p65 in the CNS of IFN-␥ ϩ ;IB␣⌬N Ϫ mice ( p Ͻ 0.0001, one-way ANOVA with Tukey's posttest; Fig. 3G-I, M ) . Although there were a few cells positive for the active form of p65 in the CNS of IFN-␥ ϩ ; IB␣⌬N ϩ mice, none of the ASPA-positive oligodendrocytes were positive for the active form of p65 in these mice (Fig. 3J-M ) . Although none of GFAP-positive astrocytes were positive for the active form of p65 in the CNS of IFN-␥ ϩ ;IB␣⌬N Ϫ mice and IFN-␥ ϩ ;IB␣⌬N ϩ mice (Fig. 3 N, O) , the majority of CD11b-positive microglia/macrophages were positive for the active form of p65 in the CNS of these mice (Fig. 3 P, Q) . Therefore, these results suggest that oligodendrocyte-specific expression of IB␣⌬N blocks NF-B activation selectively in oligodendrocytes in the CNS of IFN-␥-expressing mice.
As expected, we found that IB␣⌬N expression alone had no effect on oligodendrocytes or myelin in the CNS of 18-d-old mice (CC1, p ϭ 0.4089; EM, p ϭ 0.8057, one-way ANOVA with Tukey's posttest) and that the presence of IFN-␥ in the CNS alone noticeably reduced oligodendrocyte numbers ( p Ͻ 0.021, oneway ANOVA with Tukey's posttest) and the degree of myelination in the CNS of 18-d-old mice (Fig. 4A-C,E-G,I-K, M,N ) . Interestingly, CC1 IHC showed that the number of oligodendrocytes was further reduced in the CNS of IFN-␥ ϩ ;IB␣⌬N ϩ mice compared with IFN-␥ ϩ ;IB␣⌬N Ϫ mice ( p Ͻ 0.017, one-way ANOVA with Tukey's posttest; Fig. 4C, D, M ) . MBP IHC showed noticeably more severe myelin loss in the CNS of IFN-␥ ϩ ; IB␣⌬N ϩ mice compared with IFN-␥ ϩ ;IB␣⌬N Ϫ mice (Fig.  4G,H ) . Moreover, EM analysis showed that there were signifi- Fig. 4 I, K, L, N ) . Together, these data suggest that oligodendrocyte-specific expression of IB␣⌬N blocks NF-B activation in oligodendrocytes and results in the increased sensitivity of oligodendrocytes to the detrimental effects of IFN-␥ during development.
NF-B is a master transcription factor that regulates the expression of genes involved in inflammation (Oeckinghaus et al., 2011; Mc Guire et al., 2013; Herrington et al., 2016) . We further determined whether oligodendrocyte-specific expression of IB␣⌬N influences inflammation in the CNS of IFN-␥-expressing mice. CD11b IHC showed that the presence of IFN-␥ in the CNS alone strongly activated microglia/macrophages (Fig.  5A-C) . Nevertheless, oligodendrocyte-specific expression of IB␣⌬N had no significant effect on activation of microglia/macrophages in the CNS of IFN-␥-expressing mice (Fig. 5C,D Fig. 5I ). These results suggest that NF-B inactivation specifically in oligodendrocytes has no effect on inflammation in the CNS of IFN-␥-expressing mice. Collectively, our data indicate that NF-B activation in myelinating oligodendrocytes cell autonomously protects the cells against inflammation in the developing CNS of IFN-␥-expressing mice.
NF-B inactivation does not affect the viability or function of oligodendrocytes in the cuprizone model
The cuprizone model is regarded as one of the best mouse models to understand the processes of remyelination in the CNS and is increasingly used to study the mechanisms of remyelination in MS (Matsushima and Morell, 2001; Denic et al., 2011) . It is believed that cuprizone acts directly on mature oligodendrocytes, resulting in mature oligodendrocyte apoptosis and subsequent demyelination in the corpus callosum. Oligodendrocytes progenitor cells proliferate and differentiate within the lesion and oligodendrocytes then repopulate the area, resulting in complete remyelination after several weeks of cuprizone removal. A previous study showed that CNS-restricted deletion of IKK2 prevents mature oligodendrocyte apoptosis and demyelination in the cuprizone model; however, oligodendrocyte-restricted deletion of IKK2 had no effect on the demyelination and remyelination processes in this model (Raasch et al., 2011) . Herein, we investigated the effects of oligodendrocyte-specific expression of IB␣⌬N on oligodendrocyte apoptosis and regeneration in the cuprizone model. Six-week-old male cloxPIB␣⌬N;CNP/Cre mice (IB␣⌬N ϩ mice) and control mice (IB␣⌬N Ϫ mice), including cloxPIB␣⌬N mice, CNP/Cre mice, and wild-type mice, were treated with 0.2% cuprizone chow for up to 6 weeks. In accordance with previous reports (Matsushima and Morell, 2001; Denic et al., 2011) , there was severe oligodendrocyte loss and demyelination in the corpus callosum of IB␣⌬N Ϫ mice after 5 weeks of cuprizone treatment compared with untreated mice (Fig. 6A,C,E,F,H,J) . We found that oligodendrocyte-specific expression of IB␣⌬N did not affect oligodendrocyte loss or demyelination in the corpus callosum after 5 weeks of cuprizone treatment (p ϭ 0.8814, t test; Fig. 6A-J) . These results suggest the minimal role of NF-B in oligodendrocytes during the cuprizone-induced demyelination process.
To determine the effects of NF-B on remyelinating oligodendrocytes, 6-week-old male IB␣⌬N ϩ and IB␣⌬N Ϫ mice were treated with 0.2% cuprizone chow for 6 weeks and then returned to a normal diet for 3 weeks to allow remyelination to occur. CC1 immunostaining showed that the number of remyelinating oligodendrocytes was comparable in the corpus callosum of IB␣⌬N ϩ mice and IB␣⌬N Ϫ mice 3 weeks after cuprizone removal ( p ϭ 0.1046, t test; Fig. 6 K, L,O) . Moreover, MBP immunostaining showed that oligodendrocyte-specific expression of IB␣⌬N did not change the degree of remyelination in the demyelinated lesions significantly 3 weeks after cuprizone removal ( Fig. 6 M, N ) . Therefore, these data suggest the minimal role of NF-B in remyelinating oligodendrocytes in demyelinated lesions in adult mice.
NF-B inactivation in remyelinating oligodendrocytes aggravates IFN-␥-induced remyelination failure in the cuprizone model
Our previous studies show that the presence of IFN-␥ in the CNS suppresses oligodendrocyte regeneration and remyelination in the cuprizone-induced demyelinated lesions (Lin et al., , 2014 . Therefore, we used the cuprizone model to assess the effects of NF-B activation on remyelinating oligodendrocytes in response to IFN-␥. We found that oligodendrocyte-specific expression of IB␣⌬N did not change the number of remyelinating oligodendrocytes or the degree of remyelination significantly in the corpus callosum of the control animals 3 weeks after cuprizone removal (CC1, p ϭ 0.9552; EM, p Ͼ 0.9999; one-way ANOVA with Tukey's posttest; Fig. 7 A, B, E, F, I, J, M, N ) . Consistent with our previous studies (Lin et al., , 2014 , we found that the presence of IFN-␥ in the CNS impaired oligodendrocyte regeneration significantly ( p Ͻ 0.0037, one-way ANOVA with Tukey's post- (Fig. 7G,H) . Moreover, EM analysis confirmed that there were fewer remyelinated axons in the corpus callosum of IFN-␥ Fig. 7I-L,N) . Collectively, these data demonstrate that NF-B inactivation in remyelinating oligodendrocytes increases the sensitivity of the cells to the detrimental effects of IFN-␥ in the cuprizone model.
NF-B inactivation in mature oligodendrocytes increases the susceptibility of mice to EAE
EAE, the primary animal model used in MS research, displays many of the clinical, pathological, and immunological features of MS (Kipp et al., 2017; Lassmann and Bradl, 2017) . Our previous study demonstrated NF-B activation in oligodendrocytes in the MOG-EAE model . We examined the effects of NF-B inactivation in mature oligodendrocytes on the development of MOG-EAE. Eight-week-old female cloxPIB␣⌬N;CNP/ Cre mice (IB␣⌬N ϩ mice) and control mice (IB␣⌬N Ϫ mice), including cloxPIB␣⌬N mice, CNP/Cre mice, and wild-type mice, were immunized with MOG35-55 peptide to induce EAE. IB␣⌬N Ϫ mice developed a typical EAE disease course (Fig.  8 A, B) . Interestingly, IB␣⌬N ϩ mice developed very severe EAE: 22 of 27 mice died by PID 21 ( p ϭ 0.0367 to Ͻ0.0001, two-way ANOVA of disease course with a Sidak's multiple-comparisons test, Fig. 8A ; p Ͻ 0.0001, t test for peak score, Fig. 8B ). The majority of these mice died suddenly at ϳPID 14 (ranging from PID 10 -21) before they exhibited classical EAE clinical symptoms such as flaccid tail, hindlimb paresis, or hindlimb paralysis. Surviving IB␣⌬N ϩ mice (5 of 27) displayed EAE clinical symptoms similar to IB␣⌬N Ϫ mice (Fig. 8B) . Because of early, sudden death without obvious clinical symptoms, we were not able to collect CNS tissues to perform histopathologic analyses despite the large number of IB␣⌬N ϩ mice (n ϭ 27 animals) used in this experiment.
EAE is initiated by T-cell priming in the mouse peripheral immune system and subsequent autoimmune reactions against oligodendrocytes and myelin in the CNS (Kipp et al., 2017; Lassmann and Bradl, 2017) . We investigated whether T-cell priming was altered in IB␣⌬N ϩ mice during EAE. Spleen leukocytes were generated from IB␣⌬N ϩ mice and IB␣⌬N Ϫ mice undergoing EAE at PID 10 and their in vitro response to a secondary exposure to MOG35-55 peptide was analyzed. Interestingly, in vitro recall assays showed that the abilities of T cells generated from IB␣⌬N ϩ mice to proliferate ( p ϭ 0.0996 -0.8696, twoway ANOVA of disease course with a Sidak's multiplecomparisons test) and to produce the cytokines IFN-␥ ( p ϭ -4 ( p ϭ 0.1058, t test) , and IL-17A (P ϭ 0.0949, t test) were not changed significantly compared with those from IB␣⌬N Ϫ mice (Fig. 8C-F ) . A large number of studies demonstrate that impaired NF-B activation in inflammatory cells suppresses inflammation (Yan and Greer, 2008; Mc Guire et al., 2013; Hao et al., 2016) . Therefore, it is unlikely that the exacerbated EAE displayed by IB␣⌬N ϩ mice is due to enhanced inflammation even if there is a leaky expression of IB␣⌬N in inflammatory cells in these mice. Conversely, our studies described above showed the detrimental effects of NF-B inactivation on oligodendrocytes in response to inflammation. Several studies have shown that increased vulnerability of mature oligodendrocytes to inflammation results in increased EAE disease severity (Hisahara et al., 2001; Hussien et al., 2014 Hussien et al., , 2015 . Collectively, these data raise the possibility that NF-B inactivation in mature oligodendrocytes exacerbates EAE disease severity by rendering oligodendrocytes vulnerable to inflammation.
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Discussion
The transcription factor NF-B plays a critical role in inflammatory diseases by regulating inflammation and cell viability (Oeckinghaus et al., 2011; Mc Guire et al., 2013; Herrington et al., 2016) . NF-B can be activated by diverse stimuli, including various inflammatory mediators, growth factors, and cellular stresses, through a variety of ways, including the IKK2-dependent canonical pathway, the noncanonical pathway, and atypical pathways (Hayden and Ghosh, 2012; MinchevaTasheva and Soler, 2013) . MS and EAE are full-blown inflammatory diseases in the CNS (Frohman et al., 2006; Lassmann and Bradl, 2017) . NF-B is activated in the CNS cells in these diseases through both the IKK2-dependent pathway and IKK2-independent pathways. It is well documented that NF-B is one of master regulators of inflammation in MS and EAE (Yan and Greer, 2008; Mc Guire et al., 2013; Hao et al., 2016) . Correlative in vitro studies point to the cytoprotective effects of NF-B activation on oligodendrocytes in these diseases (Nicholas et al., 2001; Hamanoue et al., 2004; Lin et al., 2012) . However, to date, attempts to understand the role of NF-B activation in oligodendrocytes in MS and EAE have been unsuccessful.
Oligodendrocyte regeneration and subsequent remyelination is essential and necessary to restore neurological function in MS patients; however, remyelination is insufficient in MS lesions (Franklin and ffrench-Constant, 2008; Kotter et al., 2011) . (Re)myelinating oligodendrocytes must produce enormous amounts of membrane proteins and lipids to assemble myelin sheaths. Due to an extremely high rate of metabolism, (re)myelinating oligodendrocytes are highly vulnerable to inflammation (Lin and Popko, 2009; Bradl and Lassmann, 2010) . Death of (re)myelinating oligodendrocytes induced by inflammation contributes to remyelination failure in MS (Bradl and Lassmann, 2010; Watzlawik et al., 2010; Stone and Lin, 2015) . Therefore, it is important to understand the role of NF-B activation in (re)myelinating oligodendrocytes in MS lesions. In this study, we generated a mouse model that expresses IB␣⌬N, a super-suppressor of NF-B, specifically in oligodendrocytes and demonstrated that oligodendrocyte-specific expression of IB␣⌬N had no effect on (re)myelinating oligodendrocytes in the developing CNS and in cuprizone-induced demyelinated lesions. IFN-␥ is regarded as a major contributing factor to poor remyelination in MS lesions (Lin et al., , 2014 Stone and Lin, 2015) . Evidence suggests that IFN-␥ exerts its detrimental effects on (re)myelinating oligodendrocytes by stimulating inflammation and by acting directly on the cells (Popko and Baerwald, 1999; Lin et al., 2014) . Interestingly, we showed here that oligodendrocyte-specific expression of IB␣⌬N blocked NF-B activation selectively in oligodendrocytes and exacerbated myelinating oligodendrocyte death and hypomyelination, but did not alter inflammation in the developing CNS of IFN-␥-expressing mice. Moreover, we found that NF-B inactivation specifically in oligodendrocytes aggravated IFN-␥-induced remyelinating oligodendrocyte death and remyelination failure in the cuprizone model. Collectively, these results suggest that NF-B activation protects (re)myelinating oligodendrocytes cell autonomously against inflammation in MS lesions.
MS and EAE are thought to be initiated by an autoimmune reaction against oligodendrocytes and myelin (Frohman et al., Bradl and Lassmann, 2010) . Several studies have shown that mature oligodendrocyte apoptosis is the earliest structural change in newly forming demyelinating lesions in MS and EAE (Barnett and Prineas, 2004; Lin et al., 2013) . A number of studies have shown that mature oligodendrocytes with an enhanced ability to resist inflammation make mice resistant to EAE (Hisahara et al., 2000; Mc Guire et al., 2010; Lin et al., 2013) . In contrast, mature oligodendrocytes with a compromised ability to respond to inflammation render mice susceptible to EAE (Hisahara et al., 2001; Hussien et al., 2014 Hussien et al., , 2015 . We showed here that IB␣⌬N ϩ mice developed extremely severe EAE with very high mortality. Unfortunately, we were not able to collect tissues to assess tissue damage or inflammation in the CNS of these mice due to early, sudden death without noticeable clinical phenotypes. Although a number of studies demonstrate that CNP/Cre knock-in mice express Cre specifically in oligodendrocytes and Schwann cells showed that T-cell priming was not altered in IB␣⌬N ϩ mice undergoing EAE. Importantly, it is well documented that NF-B activation in inflammatory cells increases EAE disease severity (Yan and Greer, 2008; McGuire et al., 2013; Hao et al., 2016) . Therefore, the possibility that the exacerbated EAE displayed by IB␣⌬N ϩ mice is caused by enhanced inflammation due to an undesired leaky expression of IB␣⌬N in inflammatory cells is very remote. Rather, our data suggest that NF-B activation in mature oligodendrocytes is protective, protecting mice against EAE.
Although NF-B is increasingly recognized as a prosurvival transcription factor, the precise molecular mechanisms responsible for the cytoprotective effects of NF-B remain elusive. Several studies have shown that NF-B activation exerts cytoprotection through the induction of anti-apoptotic genes including cIAPs, cFLIP, Bcl-2, Bcl-x L , TRAF1, and TRAF2 (Karin and Lin, 2002; Oeckinghaus et al., 2011; Mincheva-Tasheva and Soler, 2013) . It is possible that the cytoprotective effects of NF-B on oligodendrocytes under inflammatory conditions results from the combined upregulation of multiple of these anti-apoptotic genes. Conversely, a recent study showed that upregulation of cFLIP protects cultured primary oligodendrocytes against the cytotoxicity of TNF-␣ and that downregulation of cFLIP makes oligodendrocytes sensitive to inflammation in the CNS of transgenic mice that ectopically express human IL-1␤ in astrocytes (Tanner et al., 2015) . An alternative, but not mutually exclusive, possibility is that NF-B activation protects oligodendrocytes against inflammation through induction of cFLIP. Unfortunately, the mouse models used in this study do not allow us to assess the contribution of cFLIP to the cytoprotective effects of NF-B activation on oligodendrocytes. A mouse model that allows for controllable activation of NF-B and inactivation of cFLIP specifically in oligodendrocytes would be an ideal model with which to address this important question.
Data indicate that NF-B is activated in oligodendrocytes in MS and EAE through both the IKK2-dependent pathway and IKK2-independent pathways (Yan and Greer, 2008; Mc Guire et al., 2013) . For example, our recent study shows that activation of pancreatic endoplasmic reticulum kinase (PERK) in response to endoplasmic reticulum stress suppresses IB␣ translation by phosphorylating translation initiation factor 2␣ (eIF2␣), resulting in NF-B activation in oligodendrocytes in the CNS of EAE mice . Moreover, the presence of IFN-␥ in the CNS can activate NF-B in oligodendrocytes through both the IKK2-dependent pathway and IKK2-independent pathways. For example, our previous study demonstrates that IFN-␥ can activate NF-B in oligodendrocytes by suppressing of IB␣ translation through the PERK-eIF2␣ pathway (Lin et al., 2012) . We showed here that IB␣⌬N expression eliminated NF-B activation in oligodendrocytes in the CNS of IFN-␥-expressing mice, suggesting that NF-B activation in oligodendrocytes under inflammatory conditions via both the IKK2-dependent pathway and IKK2-independent pathways can be blocked effectively by expression of IB␣⌬N. In contrast, a previous study shows that oligodendrocyte-specific deletion of IKK2 using IKK2 FL ;MOG/ Cre mice does not affect the development of EAE (Raasch et al., 2011) . The minimal effects of oligodendrocyte-specific deletion of IKK2 in EAE likely reflect the inability of IKK2 deletion alone to impair NF-B activation in the cells under inflammatory conditions.
In summary, using a mouse model that expresses IB␣⌬N, a super-suppressor of NF-B, specifically in oligodendrocytes in the CNS, the results presented in this study demonstrate the dispensable role of NF-B in oligodendrocytes under physiological conditions and the cytoprotective role of NF-B activation in oligodendrocytes in animal models of MS. These findings implicate that NF-B activation protects oligodendrocytes (both mature and remyelinating oligodendrocytes) against inflammation in MS patients, suggesting a therapeutic cytoprotective potential of NF-B activation in MS. In contrast, a number of studies have shown that NF-B activation in T cells, microglia/macrophages, or astrocytes enhances inflammation and facilitates the pathogenesis of MS and EAE, implying the therapeutic anti-inflammatory potential of NF-B inhibition in MS (Brambilla et al., 2009; Mc Guire et al., 2013; Yin et al., 2013; Hao et al., 2016) . Therefore, it is unlikely that NF-B is an ideal therapeutic target for MS due to its paradoxical effects in this disease.
